126.90CHF+0.52%Mkt Cap: 281.52B $P/E: 22.541d ago
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Pricier
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap281.52B $
Enterprise Value322.60B $
Revenue (TTM)64.57B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.56 USD
Last Price126.90 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.54
P/E (Forward)—
PEG—
EV/EBITDA12.33
EV/Revenue5.00
P/S4.36
P/B7.89
EPS (TTM)5.63
EPS (Forward)—
52W Range
108.8492% of range128.38
52W High128.38 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
Oper. Margin30.48%
EBITDA Margin40.51%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth-0.70%
Earnings Growth-9.30%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin21.25%
FCF Yield4.87%
Net Debt45.77B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh16.09 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate4.666 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.0
Float1.81B
Insiders—
Institutions—
Technical
SMA 50118.05 (+7.5%)
SMA 200118.64 (+7.0%)
Beta0.49
S&P 52W Chg20.05%
Avg Vol (30d)130.23K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)69.5
MACD2.0993
MACD Signal1.3481
MACD Hist.+0.7511
BB Upper128.00 CHF
BB Middle120.43 CHF
BB Lower112.86 CHF
BB Width12.57%
ATR (14)2.231 CHF
Vol Ratio (20d)1.00x